Patent · US Active

2′ Fluoronucleosides

US9861652B2 · kind B2 · utility

0Cited by

2References

10Claims

0Family size

Assignees

EMORY UNIVERSITY · US
University of Georgia Research Foundation, Inc. · US

Inventors

Raymond F. Schinazi · Decatur, US
Dennis C. Liotta · Atlanta, US
Chung K. Chu · Statham, US
J. Jeffrey McAtee · Atlanta, US
Junxing Shi · Duluth, US
Yongseok Choi · Athens, US
Kyeong Lee · Athens, US
Joon H. Hong · Athens, US

Key dates

Filing date	Nov 6, 2015
Grant date	Jan 9, 2018
Priority date	—
Expiry date	Nov 6, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

2′-Fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular proliferation, including tumors and cancer. The compounds have the general formulae:wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.